James P Shaffer - Net Worth and Insider Trading
James P Shaffer Net Worth
The estimated net worth of James P Shaffer is at least $2 Million dollars as of 2024-09-20. James P Shaffer is the VP & Chief Commercial Officer of Halozyme Therapeutics Inc and owns about 26,300 shares of Halozyme Therapeutics Inc (HALO) stock worth over $2 Million. James P Shaffer is also the Chief Business Officer of Eiger BioPharmaceuticals Inc and owns about 187 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $1,590. Details can be seen in James P Shaffer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James P Shaffer has not made any transactions after 2016-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James P Shaffer
James P Shaffer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James P Shaffer owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of James P Shaffer’s form 4 insider trades.
Insider Ownership Summary of James P Shaffer
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EIGRQ | Eiger BioPharmaceuticals Inc | 2016-08-18 | Chief Business Officer |
HALO | Halozyme Therapeutics Inc | 2014-02-02 | VP & Chief Commercial Officer |
James P Shaffer Latest Holdings Summary
James P Shaffer currently owns a total of 2 stocks. Among these stocks, James P Shaffer owns 26,300 shares of Halozyme Therapeutics Inc (HALO) as of November 14, 2012, with a value of $2 Million and a weighting of 99.9%. James P Shaffer also owns 187 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of August 18, 2016, with a value of $1,590 and a weighting of 0.1%.
Latest Holdings of James P Shaffer
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2012-11-14 | 26,300 | 59.24 | 1,558,012 |
EIGRQ | Eiger BioPharmaceuticals Inc | 2016-08-18 | 187 | 8.50 | 1,590 |
Holding Weightings of James P Shaffer
James P Shaffer Form 4 Trading Tracker
According to the SEC Form 4 filings, James P Shaffer has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the acquisition of 20,000 shares on November 14, 2012, which cost James P Shaffer around $104,400.
According to the SEC Form 4 filings, James P Shaffer has made a total of 0 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 104 shares on August 18, 2016, which cost James P Shaffer around $49,063.
Insider Trading History of James P Shaffer
- 1
James P Shaffer Trading Performance
GuruFocus tracks the stock performance after each of James P Shaffer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James P Shaffer is -12.12%. GuruFocus also compares James P Shaffer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James P Shaffer within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James P Shaffer's insider trading performs compared to the benchmark.
Performance of James P Shaffer
James P Shaffer Ownership Network
James P Shaffer Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
James P Shaffer is the Chief Business Officer of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, James P Shaffer made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
James P Shaffer Mailing Address
Above is the net worth, insider trading, and ownership report for James P Shaffer. You might contact James P Shaffer via mailing address: 12916 Anglewood Ct., Raleigh Nc 27614.